Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD-L1-Targeted Radionuclide Probes in Solid Tumors
NCT07848243Phase 2Recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Feb 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]F-PDL1-3 in solid tumor, sponsored by Peking University Cancer Hospital & Institute. Started Feb 2026; status: recruiting.
02
Drugs
[18F]F-PDL1-3
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07848243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07848243.